Table 3.

Statistical analysis of patient and treatment related factors between no-ART and ART groups.

		No-ART		ART		p
		Number %		Number%
Age	≤60	125	48.3	17	54.8	0.489
	˃60	134	51.7	14	45.2
KPS	90–100	172	66.4	24	77.4	0.131
	60–80	87	33.6	7	22.6
Weight loss	≤5%	128	49.4	15	48.4	0.913
	˃5%	131	50.6	16	51.6
Weight loss	≤10%	224	86.5	24	77.4	0.175
	˃10%	35	13.5	7	22.6
Nutritional interventions	No	118	45.6	10	32.3	0.171
	Yes	141	54.4	21	67.7
NG	No	225	86.9	28	90.3	0.586
	Yes	34	13.1	3	9.7
Gastrostomy	No	152	58.7	13	41.9	0.075
	Yes	107	41.3	18	58.1
Primary	Oropharynx	123	47.5	16	51.6	0.807
	Oral cavity	45	17.4	3	9.7	0.404
	Larynx	42	16.2	2	6.5	0.243
	Hypopharynx	18	6.9	5	16.1	0.151
	Unknown primary	18	6.9	0	0.0	0.262
	Sinonasal Carcinoma	10	3.9	2	6.5	0.835
	Nasopharynx	3	1.2	3	9.7	0.013
T stage	T0	22	8.5	0	0.0	0.093
	T1	39	15.1	5	16.1
	T2	85	32.8	7	22.6
	T3	57	22.0	9	29.0
	T4	56	21.6	10	32.3
N stage	N0	66	25.5	5	16.1	0.086
	N1	29	11.2	1	3.2
	N2	158	61.0	24	77.4
	N3	6	2.3	1	3.2
UICC 7th ed. Stage	I	5	1.9	2	6.5	0.858
	II	21	8.1	2	6.5
	III	41	15.8	3	9.7
	IV	192	74.1	24	77.4
Radiation	Radical	174	67.2	26	83.9	0.058
	Adjuvant	85	32.8	5	16.1
CRT	Radiotherapy	132	51.0	9	29.0	0.034
	Concurrent CRT	127	49.0	22	71.0
Induction CT	No	248	95.8	28	90.3	0.179
	Yes	11	4.2	3	9.7
mMann–Whitney u test/X² Chi-square test

KPS, Karnofsky performance status; NG, nasogastric tube; CT, chemotherapy; CRT, chemoradiotherapy.

Statistically significant values are in bold/italic.